文献速递肝胆胰外科围术期管理与 ERAS

机器人胰切除肿瘤学结局不劣于开放手术

Oncologic Outcomes After Robotic Pancreatic Resections Are Not Inferior to Open Surgery.
PubMed 文献 · Ann Surg · 2021-01-01

机器人组住院更短、伤口感染与输血更少,主要并发症及辅助化疗接受率无差异;多变量分析中机器人入路预测总生存(HR 0.77,P=0.041)。

要点

  • 机器人胰切除在肿瘤学结局上不劣于开放手术。
  • 机器人组住院7天 vs 开放9天,伤口感染与输血更少。
  • 多变量分析中机器人入路预测总生存改善(HR 0.77)。

核心结论

  • 在高 volume 经验丰富中心,机器人胰切除的肿瘤学结局不劣于开放手术,并可能因减少出血与输血而改善生存。

主要发现

  • 机器人组与开放组主要并发症及辅助化疗接受率无显著差异,入路非二者独立预测因素。
  • 机器人组住院时间短于开放组(7天 vs 9天;P < 0.001)。
  • 机器人组伤口感染率(32.3% vs 12.4%,P < 0.0001)与输血率(39.6% vs 12.4%,P < 0.0001)均低于开放组,围术期死亡率无差异。
  • 机器人组中位总生存25.6个月 vs 开放组23.9个月(P = 0.055);多变量分析中机器人入路预测总生存(HR 0.77,P = 0.041)。
  • 机器人入路为失血量减少与输血减少的独立预测因素。

临床怎么用

  • 在高 volume 经验丰富中心,机器人胰切除可作为开放手术的替代选择,其肿瘤学结局不劣且可能减少出血与输血。

局限性

  • 单中心回顾性设计,仅纳入2011至2016年病例,随访24个月,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Compare oncologic outcomes after open and robotic pancreatic resections for pancreatic adenocarcinoma (PDAC). SUMMARY OF BACKGROUND DATA: Receipt of adjuvant chemotherapy improves survival after resected PDAC. Complications after pancreatectomy have been shown to prohibit the administration of adjuvant chemotherapy and survival. We examined the effect of surgical approach on receipt of adjuvant chemotherapy, complications, and overall survival after pancreatectomy. METHODS: A single-institution retrospective review of all patients with PDAC who underwent robotic or open pancreatectomy from 2011 to 2016 with 24-month follow-up. RESULTS: Four hundred fifty-six patients underwent resection: 226 robotic and 230 open. No significant difference was identified in major complications or receipt of adjuvant chemotherapy between robotic and open pancreatectomy, nor was approach an independent predictor of these outcomes. Robotic pancreatectomy patients had a shorter length of stay than patients who underwent open pancreatectomy (7 days vs 9 days; P < 0.001). Additionally, wound infection rate (32.3% vs 12.4%, P < 0.0001) and transfusion (39.6% vs 12.4%, P < 0.0001) was improved in robotic pancreatectomy group with no differences in perioperative mortality. Improved median overall survival approached statistical significance for the robotic cohort (25.6 months vs 23.9 months; P = 0.055); however, on multivariable analysis the robotic approach predicted overall survival, (hazard ratio 0.77, P = 0.041). Robotic approach was an independent predictor of decreased blood loss and less transfusions than the open approach. CONCLUSIONS: Robotic pancreatectomy was not inferior compared to open pancreatectomy in a high-volume experienced center for oncologic outcomes and due to decreased blood loss and transfusion may have improved survival.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Girgis MD, Zenati MS, King JC, et al. Oncologic Outcomes After Robotic Pancreatic Resections Are Not Inferior to Open Surgery. Ann Surg. 2021. PMID: 31663967. doi:10.1097/SLA.0000000000003615

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。